IrishExaminer.com
HSE set to decide whether €280,000-a-year Skyclarys drug will be funded
Rare Disease Ireland has urged the HSE to continue negotiations over the cost of the treatment for Friedreich’s ataxia
Shown as published in the source's RSS feed. IndiaAIFounders doesn't link out to third-party sites — this is the complete detail available from the feed itself.